Call us for a tour today at (631) 269-5800

SJNC strictly follows NYS Department of Health and CDC guidance, which changes daily, in order to keep our residents safe. As we anticipate instructions to limit or restrict visitation, please check here before visiting. We will update information as necessary. Thank you for your understanding and cooperation.

Claudine Welti; Dr. Sydney Gary, Director of Research Operations, CSHL; Dr. Nicholas Tonks, Dagnia Zeidlickis, Trudy Calabrese, Bryan Amico

ST. JOHNLAND NURSING CENTER, Cold Spring Harbor Laboratory and U.S. Trust Company co-sponsored their thirteenth annual symposium at Cold Spring Harbor Laboratory on “Drugging an Undruggable Target – a Scientific Journey from Discovery Research to a Clinical Trial”.

The speaker, Nicholas Tonks, Ph.D, F.R.S., Professor at Cold Spring Harbor Laboratory, CSHL, detailed his work and personal journey that began with his discovery 25 years ago of a key enzyme involved in cell signaling. Although it was clear that this enzyme was a potentially powerful target for new drugs to treat human diseases, Dr. Tonks was discouraged from pursuing this line of work by major pharmaceutical firms, which pronounced the enzyme “un-druggable” – an impossible target to hit. Today, several enzyme-inhibiting drugs based on molecules Tonks designed are in development to treat diabetes, obesity, and breast cancer.